Updated: FDA Manufacturing Inspectors Could Be Further Divided Into Subspecialties
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry could benefit from smoother plant inspections.
You may also be interested in...
FDA’s New Commodity-Based Inspection Approach To Take Effect In May
FDA’s new vertically integrated and commodity-specific approach to inspections under program alignment will finally become a reality this spring. The reorganization will retain the existing district offices, but each office will have a different focus.
FDA Globalization Capacity, Shortage Monitoring Remain Concerns, GAO Says
In updated high-risk report, GAO says resources are an issue for FDA’s globalization plans and the agency should better manage its drug shortage data.
FDA Field Operations Would Endure Reductions Under Budget
President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.